Evidence map›Paper›PMID 38124291›Full record

ArticlePlant biotechnology journal2024

Rice Yellow Mottle Virus resistance by genome editing of the Oryza sativa L. ssp. japonica nucleoporin gene OsCPR5.1 but not OsCPR5.2.

Yugander Arra, Florence Auguy, Melissa Stiebner, Sophie Chéron, Michael M Wudick, Manuel Miras, Van Schepler-Luu, Steffen Köhler, Sébastien Cunnac, Wolf B Frommer and 1 more

Open access · goldAbstract read
In one paragraph

Article in Plant biotechnology journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
9.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Advances in CRISPR Plant Applications.International journal of molecular sciences · 2026
    Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 3 countries.

Yugander ArraFaculty of Mathematics and Natural Sciences, Institute for Molecular Physiology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Florence AuguyIRD, CIRAD, INRAE, PHIM Plant Health Institute of Montpellier, Institut Agro, University Montpellier, Montpellier, France.
Melissa StiebnerFaculty of Mathematics and Natural Sciences, Institute for Molecular Physiology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.ORCID 0000-0001-8626-0951
Sophie ChéronIRD, CIRAD, INRAE, PHIM Plant Health Institute of Montpellier, Institut Agro, University Montpellier, Montpellier, France.
Michael M WudickFaculty of Mathematics and Natural Sciences, Institute for Molecular Physiology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.ORCID 0000-0002-4332-369X
Manuel MirasFaculty of Mathematics and Natural Sciences, Institute for Molecular Physiology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.ORCID 0000-0002-3636-0265
Van Schepler-LuuFaculty of Mathematics and Natural Sciences, Institute for Molecular Physiology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Steffen KöhlerFaculty of Mathematics and Natural Sciences, Institute for Molecular Physiology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Sébastien CunnacIRD, CIRAD, INRAE, PHIM Plant Health Institute of Montpellier, Institut Agro, University Montpellier, Montpellier, France.
Wolf B FrommerFaculty of Mathematics and Natural Sciences, Institute for Molecular Physiology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.ORCID 0000-0001-6465-0115
Laurence AlbarIRD, CIRAD, INRAE, PHIM Plant Health Institute of Montpellier, Institut Agro, University Montpellier, Montpellier, France.
Heinrich Heine University Düsseldorf · DECentre de Coopération Internationale en Recherche Agronomique pour le Développement · FR

Funding

Alexander von Humboldt-StiftungConsortium of International Agricultural Research Centers RICE 2017-2022Deutsche ForschungsgemeinschaftH2020 Marie Skłodowska-Curie Actions 101023981
6 · The paper itself

Abstract

Rice yellow mottle virus (RYMV) causes one of the most devastating rice diseases in Africa. Management of RYMV is challenging. Genetic resistance provides the most effective and environment-friendly control. The recessive resistance locus rymv2 (OsCPR5.1) had been identified in African rice (Oryza glaberrima), however, introgression into Oryza sativa ssp. japonica and indica remains challenging due to crossing barriers. Here, we evaluated whether CRISPR/Cas9 genome editing of the two rice nucleoporin paralogs OsCPR5.1 (RYMV2) and OsCPR5.2 can be used to introduce RYMV resistance into the japonica variety Kitaake. Both paralogs had been shown to complement the defects of the Arabidopsis atcpr5 mutant, indicating partial redundancy. Despite striking sequence and structural similarities between the two paralogs, only oscpr5.1 loss-of-function mutants were fully resistant, while loss-of-function oscpr5.2 mutants remained susceptible, intimating that OsCPR5.1 plays a specific role in RYMV susceptibility. Notably, edited lines with short in-frame deletions or replacements in the N-terminal domain (predicted to be unstructured) of OsCPR5.1 were hypersusceptible to RYMV. In contrast to mutations in the single Arabidopsis AtCPR5 gene, which caused severely dwarfed plants, oscpr5.1 and oscpr5.2 single and double knockout mutants showed neither substantial growth defects nor symptoms indicative lesion mimic phenotypes, possibly reflecting functional differentiation. The specific editing of OsCPR5.1, while maintaining OsCPR5.2 activity, provides a promising strategy for generating RYMV-resistance in elite Oryza sativa lines as well as for effective stacking with other RYMV resistance genes or other traits.

Indexed as

ArabidopsisOryzaPlant VirusesGene EditingNuclear Pore Complex ProteinsNuclear Pore Complex ProteinsCRISPR/Cas9disease resistancegenome editingknockout mutantnucleoporinrecessive

Identifiers

PMID38124291
PMCPMC11022797
OpenAlexW4390056812

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.